HealthTree

Your Feed

Filter by

See content from

Back to the latest

XimenaG • Admin

Follicular Lymphoma Discussion • December 29

Thank You for Sharing Your Stories

As we close our 'Why I Give' campaign, we would like to thank every patient, caregiver, supporter, volunteer, and team member who shared their reason. Your voices filled this season with hope. At HealthTree, YOU are the heart of our mission. Your courage, your stories, and your willingness to stand with us are what move research forward and bring us closer to cures every day. Thank you for showing up. Thank you for believing in what’s possible. #WhyIGive #WeCareWeCure #HealthTreeGives #BloodCancerCommunity #TogetherForACure

Thumbnail for High-Risk DLBCL: GOLCA Boosts Remission Rates | Marc Hoffmann, MD

Playlist: ASH 2025

High-Risk DLBCL: GOLCA Boosts Remission Rates | Marc Hoffmann, MD

Video details & playlist

Thumbnail for Chemo-Free Option for Frail Lymphoma Patients | Umberto Vitolo, MD

Playlist: ASH 2025

Chemo-Free Option for Frail Lymphoma Patients | Umberto Vitolo, MD

Video details & playlist

Thumbnail for What Happens When You Add Mosunetuzumab + Polatuzumab to CAR‑T (axi‑cel)? | Jay Spiegel, MD

Playlist: ASH 2025

What Happens When You Add Mosunetuzumab + Polatuzumab to CAR‑T (axi‑cel)? | Jay Spiegel, MD

Video details & playlist

Thumbnail for SMART STOP Trial: Targeted Drugs Before Chemo in B-Cell Lymphoma? | Jason Westin, MD

Playlist: ASH 2025

SMART STOP Trial: Targeted Drugs Before Chemo in B-Cell Lymphoma? | Jason Westin, MD

Video details & playlist

Thumbnail for Can Epcoritamab Improve Outcomes in R-mini-CHOP Patients? | Chan Cheah, MD, PhD

Playlist: ASH 2025

Can Epcoritamab Improve Outcomes in R-mini-CHOP Patients? | Chan Cheah, MD, PhD

Video details & playlist

Thumbnail for Emerging Treatment for CD30-Positive Lymphoma: A Phase 1 Study | Swetha Thiruvengadam, MD

Playlist: ASH 2025

Emerging Treatment for CD30-Positive Lymphoma: A Phase 1 Study | Swetha Thiruvengadam, MD

Video details & playlist

Latest Follicular Lymphoma Research from ASH 2025

Latest Follicular Lymphoma Research from ASH 2025 image

Virtual Reality and Hypnosis May Help Ease Anxiety Before a Bone Marrow Procedure

Virtual Reality and Hypnosis May Help Ease Anxiety Before a Bone Marrow Procedure image

Medicare Open Enrollment for Those Already in a Medicare Advantage Plan

Medicare Open Enrollment for Those Already in a Medicare Advantage Plan image

Thumbnail for Promising Therapy for Hard-to-treat DLBCL: Epcoritamab + GemOx #DLBCL | Joshua Brody, MD

Playlist: ASH 2025

Promising Therapy for Hard-to-treat DLBCL: Epcoritamab + GemOx #DLBCL | Joshua Brody, MD

Video details & playlist

Palliative Care in Blood Cancer: Meeting Patient Needs At Every Stage

Palliative Care in Blood Cancer: Meeting Patient Needs At Every Stage image

How Integrative Oncology Supports Your Health

How Integrative Oncology Supports Your Health image

U.S. FDA Approves Liso-cel (Breyanzi) for Marginal Zone Lymphoma

U.S. FDA Approves Liso-cel (Breyanzi) for Marginal Zone Lymphoma image

ASH 2025: New CAR T-Cell Therapies for Relapsed B-Cell Lymphoma

ASH 2025: New CAR T-Cell Therapies for Relapsed B-Cell Lymphoma image

Why I Give: Sue Hultgren's Story

Why I Give: Sue Hultgren's Story image

Federal Funding Drives Breakthroughs in Rare Diseases

Federal Funding Drives Breakthroughs in Rare Diseases image

Read HealthTree’s First Issue of Care and Cure Magazine Today

Read HealthTree’s First Issue of Care and Cure Magazine Today image

FMLA Explained: Protected Leave for Caregivers

FMLA Explained: Protected Leave for Caregivers image

Thumbnail for What should patients expect during and after treatment with CAR T-cell therapy?

Playlist: CAR-T Therapy

What should patients expect during and after treatment with CAR T-cell therapy?

Video details & playlist

Managing Family Dynamics During Cancer Care

Managing Family Dynamics During Cancer Care image

Why I Give to HealthTree

Thumbnail for Which drugs are FDA approved for bispecific therapy and how do they work?

Playlist: Bispecific Antibodies in DLBCL

Which drugs are FDA approved for bispecific therapy and how do they work?

Video details & playlist

U.S. FDA Approves Epcoritamab (Epkinly) Combination for Follicular Lymphoma

U.S. FDA Approves Epcoritamab (Epkinly) Combination for Follicular Lymphoma image

More from HealthTree